A New Neural Gauge for Autism: The Brain’s Electrical Baseline Holds Clues
Recent research in Psychiatry and Clinical Neurosciences investigates the neural excitation-inhibition (E/I) balance in autism spectrum disorder (ASD) using resting-state electroencephalography (EEG). The study analyzed the aperiodic component of EEG signals, which reflects the brain’s background neural activity, in 63 autistic adolescents and adults compared to 53 non-autistic controls. Findings revealed that autistic individuals exhibited a flatter spectral power slope and a smaller offset, indicative of a shifted E/I ratio. This neurophysiological signature was correlated with clinical measures, showing that a lower aperiodic exponent was associated with higher overall autistic traits, greater difficulty in mindreading, and challenges with sensory registration and working memory.
Study Significance: For immunology and neuroimmunology researchers, this work provides a crucial bridge between systemic immune function and central nervous system activity. The identified E/I imbalance may intersect with known neuroinflammatory pathways and cytokine signaling in ASD, offering a quantifiable electrophysiological endpoint for studies on immune-mediated neuromodulation. This objective biomarker could significantly refine patient stratification in clinical trials for immunotherapies or anti-inflammatory interventions, moving beyond behavioral assessments to target underlying neurophysiological mechanisms.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
